Natreon​ ​expands​ ​its​ ​global​ ​intellectual​ ​property​ ​portfolio with​ ​additional​ ​patents​ ​granted​ ​for​ ​its​ ​platform of​ ​branded​ ​botanical​ ​ingredients,​ ​including: Capros®,​ ​Ayuric®​ ​and​ ​a​ ​new​ ​bioactive​ ​from​ ​Sensoril®

Natreon has been granted U.S., Chinese and Japanese patents for a new bioactive isolated from Sensoril®, an aqueous extract of ashwaghanda. These additional domestic and global patents cover the recent discovery of a new class of compounds, Indolealkylamino-withasteroid conjugates, and their significant acetylcholinesterase inhibitory activity.

Additionally, Natreon has been granted a U.S. patent for its Ayuric® ingredient whose claims support the use of Ayuric®, a standardized extract of Terminalia bellirica, for the treatment of gout, uricemia and hyperuricemia.

Finally, the Canadian patent office issued a patent for Natreon’s super antioxidant ingredient, Capros®, a standardized extract of Phyllanthus emblica, which covers a composition and method to treat or prevent endothelial dysfunction. These additional issued patents support Natreon’s focus on investing in product innovation and clinical studies to support the ingredients it brings to market.

Continue Reading for the Full Press Release

Recent Posts

Leave a Comment